Suchergebnisse - "Liang, Licong"

PubPharm (23)

1

Lenvatinib, sintilimab plus transarterial chemoembolization for advanced stage hepatocellular carcinoma : A phase II study

enthalten in: Liver international : official journal of the International Association for the Study of the Liver | 2024

von Cai, M. | Huang, W. | Liang, W. | +9

2

Epidemiological and clinical characteristics of open globe injuries in Southwest China

enthalten in: Frontiers in medicine | 2024

von Chen, Q. | Liang, L. | Shi, Y. | +1

3

Lenvatinib, sintilimab plus transarterial chemoembolization for advanced stage hepatocellular carcinoma : A phase II study

enthalten in: Liver International | 2024

von Cai, M. | Huang, W. | Liang, W. | +9

4

Visual Acuity-Related Outer Retinal Structural Parameters on Swept Source Optical Coherence Tomography and Angiography in XLRS Patients and Carriers

enthalten in: Translational vision science & technology | 2023

von Tao, Z. | Bu, S. | Liang, L. | +3

5

Mechanisms and therapeutic strategies to combat the recurrence and progression of hepatocellular carcinoma after thermal ablation

enthalten in: Journal of interventional medicine | 2023

von Ye, F. | Xie, L. | Liang, L. | +5

6

Tyrosine-kinase inhibitor combined with iodine-125 seed brachytherapy for hepatocellular carcinoma refractory to transarterial chemoembolization : a propensity-matched study

enthalten in: Cancer imaging : the official publication of the International Cancer Imaging Society | 2023

von Guo, Y. | Wu, J. | Liang, L. | +9

7

Tyrosine-kinase inhibitor combined with iodine-125 seed brachytherapy for hepatocellular carcinoma refractory to transarterial chemoembolization: a propensity-matched study

enthalten in: Cancer imaging | 2023

von Guo, Y. | Wu, J. | Liang, L. | +9

8

Blocking Th2 Signaling Pathway Alleviates the Clinical Symptoms and Inflammation in Allergic Conjunctivitis

enthalten in: Investigative ophthalmology & visual science | 2023

von Tao, Z. | Liu, W. | Chen, Q. | +8

9

Regorafenib enhances anti-tumor efficacy of immune checkpoint inhibitor by regulating IFN-γ/NSDHL/SREBP1/TGF-β1 axis in hepatocellular carcinoma

enthalten in: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie | 2023

von Xie, L. | Liu, M. | Cai, M. | +10

10

Inhibition of CEMIP potentiates the effect of sorafenib on metastatic hepatocellular carcinoma by reducing the stiffness of lung metastases

enthalten in: Cell death & disease | 2023

von Liu, M. | Xie, L. | Zhang, Y. | +11